| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 316.00K | -20.08M | -5.85M | -3.29M | 22.82M | 43.20M |
| Gross Profit | -682.00K | -22.14M | -5.85M | -3.29M | 22.82M | 43.20M |
| EBITDA | 39.51M | -23.41M | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.09M | -23.44M | -6.72M | -4.09M | 22.15M | 42.70M |
Balance Sheet | ||||||
| Total Assets | 225.47M | 184.89M | 189.17M | 182.91M | 160.97M | 125.09M |
| Cash, Cash Equivalents and Short-Term Investments | 4.13M | 1.44M | 4.93M | 1.37M | 5.20M | 15.69M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.34M | 1.38M | 1.61M | 1.71M | 3.15M | 2.11M |
| Stockholders Equity | 224.14M | 183.51M | 187.56M | 181.21M | 157.82M | 122.56M |
Cash Flow | ||||||
| Free Cash Flow | -126.00K | -799.00K | -173.00K | -2.41M | -1.25M | -493.00K |
| Operating Cash Flow | -126.00K | -799.00K | -173.00K | -2.41M | -1.25M | -493.00K |
| Investing Cash Flow | -3.54M | -22.10M | -9.33M | -28.87M | -22.34M | 6.62M |
| Financing Cash Flow | 5.22M | 19.40M | 13.07M | 27.48M | 13.10M | -230.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £27.39B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
76 Outperform | £197.51M | 4.34 | 12.32% | 8.15% | 1.29% | 11.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.68B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
63 Neutral | ― | 16.79 | 4.39% | 0.80% | ― | -36.39% | |
57 Neutral | ― | 1.33 | -0.94% | ― | -98.40% | -113.47% | |
52 Neutral | £704.97M | -13.08 | 2.49% | 1.22% | -37.43% | -67.39% |